Medical Devices & Surgical Technology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices & Surgical Technology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business & Finance
CoTherix reports increasing Ventavis sales, provides Q4 and 2005 results
April 11th, 2006
CoTherix, Inc., (CTRX) reported results for its fourth quarter and year ended December 31, 2005. Net product sales from the company's Ventavis Inhalation Solution in the fourth quarter of 2005 were $11 million, up 30% from $8.4 million in the third quarter of 2005. Total 2005 net product sales for Ventavis, which was launched in March 2005, were $23.9 million. "[Last year] was a tremendous year for CoTherix as we successfully transitioned into a commercial organization with the launch of Ventavis for pulmonary arterial hypertension. We've established critical talent in sales, marketing, and reimbursement and intend to leverage this commercial...
Source: Medical Devices & Surgical Technology Week (2006-04-11)
|
